Literature DB >> 8758243

Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.

G Buccheri1, D Ferrigno, M Tamburini.   

Abstract

The Karnofsky's index of performance status (KPS) and the Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS) are widely used methods of assessing the functional status of cancer patients. In this study, we compare their predictive validity, and suggest a table of transformation between scales. 536 consecutive lung cancer patients were assigned both KPS and ECOG PS scores before, during and after treatment (in all, 1656 assignments). Patients were accurately staged at diagnosis, and carefully re-evaluated at each follow-up visit. Multiple clinical, laboratory and instrumental data were recorded along with performance status assessments. Survival times were measured from the pathological diagnosis. KPS and ECOG PS assignments were strongly related to each other (Spearman R = -0.869). Correlation between scales persisted unchanged in pretreatment and post-treatment assessments, advanced and limited diseases, response or non-response to treatment, and different assessors (R indices ranging from -0.825 to -0.901). A three-point conversion table showed the highest rate of success with an overall percentage of agreement exceeding 84% (grade 1: KPS = 100, 90, 80 and ECOG PS = 0, 1; grade 2: KPS = 70, 60 and ECOG PS = 2; grade 3: KPS < 60 and ECOG PS = 3, 4). Both univariate and multivariate analyses of survival documented the predictive validity of the two scales. However, KPS showed less ability than ECOG PS to discriminate patients with different prognosis. Because of the better predictive ability shown in this study, ECOG PS should be preferred to KPS. A general consensus on the scale to use could avoid problems of conversion, which is not always easy and free of errors.

Entities:  

Mesh:

Year:  1996        PMID: 8758243     DOI: 10.1016/0959-8049(95)00664-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  156 in total

1.  Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

Authors:  Fidel-David Huitzil-Melendez; Marinela Capanu; Eileen M O'Reilly; Austin Duffy; Bolorsukh Gansukh; Leonard L Saltz; Ghassan K Abou-Alfa
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

2.  Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.

Authors:  Charles Lu; J Jack Lee; Ritsuko Komaki; Roy S Herbst; Lei Feng; William K Evans; Hak Choy; Pierre Desjardins; Benjamin T Esparaz; Mylene T Truong; Scott Saxman; Joseph Kelaghan; Archie Bleyer; Michael J Fisch
Journal:  J Natl Cancer Inst       Date:  2010-05-26       Impact factor: 13.506

3.  The role of airway stent placement in the management of tracheobronchial stenosis caused by inoperable advanced lung cancer.

Authors:  Kinya Furukawa; Junzo Ishida; Gaku Yamaguchi; Jitsuo Usuda; Hidemitsu Tsutsui; Makoto Saito; Chimori Konaka; Harubumi Kato
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

4.  Predictors of functional capacity in colorectal cancer patients.

Authors:  Murat Tomruk; Didem Karadibak; Tuğba Yavuzşen; Tülay Akman
Journal:  Support Care Cancer       Date:  2015-02-08       Impact factor: 3.603

5.  Analysis of ECOG performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival.

Authors:  Gefter Thiago Batista Corrêa; Gabriela Alencar Bandeira; Bruna Gonçalves Cavalcanti; Francis Balduíno Guimarães Santos; João Felício Rodrigues Rodrigues Neto; André Luiz Sena Guimarães; Desirée Sant'Ana Haikal; Alfredo Maurício Batista De Paula
Journal:  Support Care Cancer       Date:  2012-11       Impact factor: 3.603

6.  Novel clinical staging for patients with end-stage gastrointestinal carcinoma.

Authors:  Naokuni Yasuda; Osamu Nakashima; Toru Ohnaka; Koji Kamisaka; Akira Tsunoda; Mitsuo Kusano
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

7.  Psychometric evaluation and feasibility of the Greek Pittsburgh Sleep Quality Index (GR-PSQI) in patients with cancer receiving chemotherapy.

Authors:  Grigorios C Kotronoulas; Constantina N Papadopoulou; Anastasia Papapetrou; Elisabeth Patiraki
Journal:  Support Care Cancer       Date:  2010-10-23       Impact factor: 3.603

8.  Optimizing follow-up and study retention in the 21st century: Advances from the front line in alcohol and tobacco research.

Authors:  Lia J Smith; Patrick J McNamara; Andrea C King
Journal:  Drug Alcohol Depend       Date:  2017-04-15       Impact factor: 4.492

9.  Lower Pectoralis Muscle Area Is Associated with a Worse Overall Survival in Non-Small Cell Lung Cancer.

Authors:  C Matthew Kinsey; Raul San José Estépar; Jos van der Velden; Bernard F Cole; David C Christiani; George R Washko
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-19       Impact factor: 4.254

Review 10.  Lung cancer in elderly patients.

Authors:  Federico Venuta; Daniele Diso; Ilaria Onorati; Marco Anile; Sara Mantovani; Erino A Rendina
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.